An interventional study of Dilatation and No dilatation in Hypospadias and Fistula Stenosis, sponsored by University of Faisalabad. Enrolling by invitation at 1 site in Pakistan. Open to male participants aged 6 Months to 15 Years. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by University of Faisalabad · Not applicable, Interventional, and Prevention
This Study with compare that how will urethral dilatation post hypospadias surgery will effect formation of fistula formation
Hypospadias is presence of urethral opening on undersurface of penis. Repair of hypospadias is associated with formation of fistula. In this study we will compare how will urethral dilatation will effect fistula formation rate and vice versa.
123 studies on the registry are indexed under Hypospadias; 34 are open to participants now.
This study's planned enrollment of 150 is above the median of 70 across 97 interventional studies indexed under Hypospadias.
Browse Hypospadias studies →University of Faisalabad is the lead sponsor of 87 studies on the registry; 28 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Male children aged 6 months to 15 years
Exclusion Criteria:
Previous hypospadias surgery
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Neo urethral Dilatation will be done in one group of patients
Other: Dilatation
No Neo urethral dilatation will be done in second group
Other: No dilatation
Neo urethral dilatation will done in one group
No dilatation will be done in second group
Fistula Fromation
We will observe that which what will be rate of fistula formation in both groups
Time frame: UpTo 6 months after surgery
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2027; primary completion for Jan 2028, 12 months later.
Of 60 non-industry interventional studies with no phase under Hypospadias, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 39. This study's planned 12 months is below that.
Counting every sponsor, half of 60 studies reached it within 15 months; a quarter within 8 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Faisalabad